Analysis of the vaccination status of enterovirus type 71 inactivated vaccine in China from 2017 to 2021.
10.3760/cma.j.cn112338-20220811-00704
- Author:
Lin ZHANG
1
;
Lei CAO
1
;
Yan LI
1
;
Ying Xue HU
1
;
Lin TANG
1
;
Ke Li LI
1
;
Zun Dong YIN
1
;
Zhi Jie AN
1
Author Information
1. Department of National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Enterovirus A, Human;
Hand, Foot and Mouth Disease/prevention & control*;
Vaccines, Inactivated;
Viral Vaccines;
Enterovirus;
Vaccination;
China/epidemiology*
- From:
Chinese Journal of Epidemiology
2023;44(4):561-567
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To understand the vaccination status of enterovirus type 71 (EV71) inactivated vaccines in China from 2017 to 2021 and provide evidence for making policy on immunization strategy against hand, foot and mouth disease (HFMD). Methods: Using the reported dose number of EV71 vaccination and birth cohort population data collected by the China immunizaiton program information system to estimate the cumulative coverage of EV71 vaccine by the end of 2021 among the birth cohorts since 2012 at national, provincial, and prefecture levels, and analyze the correlation between the vaccination coverage and the potential influencing factors. Results: As of 2021, the estimated cumulative vaccination coverage of the EV71 vaccine was 24.96% in birth cohorts since 2012. The cumulative vaccination coverage was between 3.09% and 56.59% in different provinces, between 0 and 88.17% in different prefectures. There was a statistically significant correlation between vaccination coverage in different regions and the region's previous HFMD prevalence and disposable income per capita. Conclusions: Since 2017, the EV71 vaccines have been widely used nationwide, but the coverage of EV71 vaccination varies greatly among regions. Vaccination coverage is higher in relatively developed regions, and the intensity of previous epidemic of HFMD may have a certain impact on the acceptance of the vaccine and the pattern of immunization service. The impact of EV71 vaccination on the epidemic of HFMD requires further studies.
